1. Home
  2. DDS vs IBRX Comparison

DDS vs IBRX Comparison

Compare DDS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$599.28

Market Cap

9.5B

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.72

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
IBRX
Founded
1938
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
DDS
IBRX
Price
$599.28
$8.72
Analyst Decision
Sell
Strong Buy
Analyst Count
3
7
Target Price
$519.67
$12.57
AVG Volume (30 Days)
113.2K
28.4M
Earning Date
02-24-2026
02-23-2026
Dividend Yield
5.18%
N/A
EPS Growth
N/A
38.71
EPS
N/A
N/A
Revenue
N/A
$113,288,000.00
Revenue This Year
$1.06
$88.57
Revenue Next Year
$2.02
$146.98
P/E Ratio
$18.08
N/A
Revenue Growth
N/A
668.31
52 Week Low
$282.24
$1.83
52 Week High
$741.98
$12.43

Technical Indicators

Market Signals
Indicator
DDS
IBRX
Relative Strength Index (RSI) 48.07 55.55
Support Level $586.59 $2.27
Resistance Level $634.02 $12.43
Average True Range (ATR) 23.88 0.70
MACD -0.08 -0.20
Stochastic Oscillator 51.09 30.00

Price Performance

Historical Comparison
DDS
IBRX

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: